Loading
Latest filing published 18 Jan 2024 for Innoveren Scientific, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Todd R. Wagner discloses dealings in H-Cyte, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 23 February 2022 to 16 January 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 18 January 2024 with a transaction in H-Cyte, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations